Source: GWASCAT
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 10 | 8 | 2009 | 2018 | ||||||||
|
transmembrane serine protease 6 | 0.584 | 0.654 | 4.1E-10 |
|
phenotype | 0.100 | None | 1.000 | 10 | 5 | 2009 | 2019 | ||||||||
|
family with sequence similarity 234 member A | 1.000 | 0.077 | 1.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 9 | 8 | 2009 | 2019 | ||||||||
|
HBS1 like translational GTPase | 0.705 | 0.462 | 1.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 7 | 7 | 2009 | 2018 | ||||||||
|
RNA terminal phosphate cyclase like 1 | 0.792 | 0.192 | 5.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 7 | 4 | 2009 | 2018 | ||||||||
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 3 | 2009 | 2018 | ||||||||
|
ubiquitin conjugating enzyme E2 L3 | 0.644 | 0.615 | 0.84 |
|
phenotype | 0.100 | None | 1.000 | 5 | 5 | 2010 | 2018 | ||||||||
|
membrane associated ring-CH-type finger 8 | 0.590 | 0.692 | 5.9E-07 |
|
phenotype | 0.100 | None | 1.000 | 5 | 7 | 2009 | 2017 | ||||||||
|
coiled-coil domain containing 162, pseudogene | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2009 | 2018 | |||||||||
|
thyroid hormone receptor beta | 0.554 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2010 | 2018 | ||||||||
|
exportin 7 | 0.931 | 0.077 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2010 | 2018 | ||||||||
|
transferrin receptor | 0.437 | 0.885 | 7.0E-05 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2009 | 2018 | ||||||||
|
NPR3 like, GATOR1 complex subunit | 0.678 | 0.385 | 0.19 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2013 | 2018 | ||||||||
|
homeostatic iron regulator | 0.436 | 0.846 | 2.6E-08 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2009 | 2012 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2013 | 2017 | ||||||||
|
RAB11A, member RAS oncogene family | 0.601 | 0.692 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2012 | 2018 | ||||||||
|
farnesyltransferase, CAAX box, beta | 1.000 | 0.077 | 7.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2017 | ||||||||
|
MYC associated factor X | 0.553 | 0.769 | 0.83 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2017 | ||||||||
|
chromosome 18 open reading frame 25 | 0.931 | 0.231 | 0.89 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2018 | ||||||||
|
phospholipase C like 2 | 0.743 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2016 | 2018 | ||||||||
|
tripartite motif containing 58 | 0.769 | 0.115 | 1.3E-10 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2016 | 2018 | |||||||||
|
RNA binding protein, mRNA processing factor | 0.780 | 0.423 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2018 | ||||||||
|
CHURC1-FNTB readthrough | 5.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2017 | ||||||||||
|
long intergenic non-protein coding RNA 1221 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2018 |